Dr. Raj Nagarkar's Robotic Surgery Master Class at MASICON 2024

The Maharashtra State chapter of the Association of Surgeons of India (ASI) recently hosted a 3-day MASICON event in Nashik. The event aimed to enhance medical-surgical education and facilitate engagement in scientific programs and discussions.

Providence Expands Healthcare Innovation in Hyderabad

Providence India, a global healthcare engineering, operations, and innovation center, has opened a new office in Hyderabad. The company has also announced plans to double its workforce in India to meet the growing demand for tech-enabled healthcare.

Cadila Pharma Introduces Vitamin D Injection

Cadila Pharma has recently launched the world's first aqueous formulation of cholecalciferol for vitamin D deficiency.

FDA Priority Review for Dupixent's COPD Treatment

The supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) as an add-on maintenance treatment for adult patients with uncontrolled chronic obstructive pulmonary disease (COPD)

Chemex Global Opens API Plant in Guwahati

Chemex Global, a research-driven pharmaceutical company, has opened its first Active Pharmaceutical Ingredients (API) manufacturing facility in Guwahati, Assam.

AIIMS-like Healthcare for India's $3 Trillion Economy: PM Modi

Prime Minister Narendra Modi has stated that the All India Institute of Medical Sciences (AIIMS) provides the kind of healthcare services that India should aspire to in its march towards becoming a USD 3 trillion economy and a developed country.

Americord's Cord Blood Stem Cells for Motor Neuron Disease Treatment

Americord, a leading private stem cell bank, has announced the release of cord blood stem cells to a client's grandmother in India to treat motor neuron disease.

FDA Clears ROSA Shoulder System for Robotic Shoulder Replacement

Zimmer Biomet Holdings, Inc. has announced that the US Food and Drug Administration (FDA) has cleared the ROSA Shoulder System for robotic-assisted shoulder replacement surgery.

LAI Announces Revised Guidelines For Indian Heart Patients

The Lipid Association of India (LAI) announces Revised guidelines on heart disease for patients in India. The updated guidelines include new data on cardiovascular risk assessment and lipid management. According to new guidelines, patients have...

Orchid Pharma Secures USFDA Nod For Enmetazobactam

Orchid Pharma has been granted approval by the USFDA for their novel invention, Enmetazobactam. This comes soon after a recommendation for approval by the European Medicines Agency (EMA). Enmetazobactam is the first beta-lactamase inhibitor to...

© 2025 India Pharma Outlook. All Rights Reserved.